Compounded semaglutide vs brand name Wegovy: what is the real difference?

Short answer

• Wegovy is an FDA‑approved, branded semaglutide product made and tested by Novo Nordisk for weight loss. Compounded semaglutide is made by a compounding pharmacy from bulk drug substance or repackaged product and is not FDA‑approved. That difference drives the main tradeoffs: regulatory oversight, quality control, dosing/packaging consistency, legal/insurance coverage, and safety data.

Key differences (what matters to patients)

• Regulatory approval and evidence
  • Wegovy: went through clinical trials, FDA review and approval for chronic weight management at a specified dosing schedule (titration up to 2.4 mg weekly). Safety and efficacy are well documented.
  • Compounded semaglutide: not FDA‑approved as a finished product. It lacks Wegovy’s clinical trial backing and specific approval for weight loss formulations.
• Manufacturing quality and testing
  • Wegovy: manufactured under strict company controls and tested for purity, potency, sterility (as applicable), stability, and labeled with lot info and expiration dates.
  • Compounded: quality depends on the pharmacy. Some high‑quality 503B outsourcing facilities follow stricter practices, but many 503A compounding pharmacies have variable processes. Risks include incorrect concentration, contamination, or instability.
• Dosing accuracy and delivery device
  • Wegovy: prefilled, calibrated injection pens designed to deliver precise doses and follow the approved titration schedule.
  • Compounded: often provided in vials that require drawing with syringes or in non‑standard syringes/pens; this increases the chance of dosing errors.
• Safety and traceability
  • Wegovy: adverse events and manufacturing issues are traceable to the manufacturer; full prescribing information exists (contraindications, boxed warnings, monitoring).
  • Compounded: harder to trace problems back to a source; may not carry the same safety labeling or long‑term data.
• Cost and insurance
  • Wegovy: often expensive; insurance coverage varies but manufacturer savings programs may help.
  • Compounded: typically cheaper out‑of‑pocket but rarely covered by insurance and involves the tradeoffs above.

When a compounded product can be relatively safer

• If you must use a compound (usually for cost reasons), choose a reputable source:
  • Prefer an FDA‑registered 503B outsourcing facility or a compounding pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB).
  • Ask the pharmacy for Certificate(s) of Analysis (COA) from third‑party testing, sterility test results (if sterile), lot numbers, expiry/stability data, and storage/handling instructions.
  • Verify cold‑chain handling and ask your prescriber to supervise dose calculations and administration technique.

Practical recommendations (what I’d do or tell a patient)

1. If you want the proven, safest option, get Wegovy (Novo Nordisk): consistent dosing, known efficacy and safety, and the prefilled pen avoids dosing mistakes.
2. If cost is prohibitive, discuss alternatives with your prescriber:
   • Ask about manufacturer savings programs or insurance appeals for Wegovy.
   • Ask about FDA‑approved alternatives for weight management (for example, tirzepatide brand Zepbound is FDA‑approved for weight loss — speak with your clinician about appropriateness).
3. If you consider compounded semaglutide, insist on a reputable provider:
   • Use a PCAB‑accredited pharmacy or an FDA‑registered 503B outsourcing facility (e.g., large national 503B providers such as Fagron Sterile Services are examples — always verify current accreditations).
   • Get documentation (COA, sterility, stability), and use a prescriber who will supervise dosing and follow you closely for side effects.
4. Avoid unknown online sellers or “cheap” clinics with no transparency — risk of counterfeit, contaminated, or wrongly dosed product is real.

Bottom line Wegovy = FDA‑approved, standardized, clinically studied, and designed for weight loss with precise pens and known titration and safety profile. Compounded semaglutide = potentially cheaper but variable quality, not FDA‑approved, may have greater risk of dosing/sterility/contamination issues and lacks Wegovy’s safety/efficacy data. Prefer Wegovy when possible; if using compounded, use only reputable, accredited compounders and insist on transparency and clinician oversight.